News &
Our Thoughts on Tech

近年粵港澳大灣區吸納資金及初創企業能力不斷提升，Saltagen 向本報透露，未來冀將加拿大的初創企業，通過香港平台帶到大灣區的內地城市...

Oncoustics, the world's leader in Artificial Intelligence (AI) based analytics for processing raw ultrasound signal to do tissue characterization, real-time diagnostics and non-invasive surveillance, announced that, in association with University Health Network (UHN), they have been awarded an Early Access Health Network Grant to trial the OnX Liver Assessment Solutions in UHN clinics...

Sympatic is a zero-copy data collaboration platform that enables healthcare and life sciences companies to leverage sensitive data with no data transfer and complete privacy protection...

不過疫情卻對生物科技發展帶來很大契機，Joseph 表示，「因為出現通脹及封關等問題，影響全球初創的融資金額，今年亞洲的創投規模更出現大幅度下調，投資者也在思考什麼是好的投資，反而出現良性的市場修正，例如會見到不少零售科技估值過高...

Sympatic, a data collaboration platform that allows users to create and manage safe data sandboxes in their cloud of choice, today announced that it has raised a pre-seed round of funding led by Saltagen Ventures with participation from ScaleGood Fund.

Oncoustics, the leader in ultrasound-based tissue characterization solutions announces the initial close of a $5 million+ seed round of funding to advance its SaMD (software as a medical device) technology for the low-cost assessment of structural diseases at point of care.

Oncoustics has raised about $5.5 million CAD ($4.3 million USD) in seed funding to disrupt liver care by facilitating easier early disease detection, diagnosis, and patient management...

生物科技是全球發展最快行業之一，香港馬首是瞻，近年人才資金逐漸靠攏，各初創企業大展拳腳，期望憑技術打出一片天空。有投資者看好行業發展，成立目標規模10億港元的基金...

本港深度技術（Deep Tech）創投公司Saltagen Ventures近日宣布，推出第二輪生物科技基金（Saltagen Global Fund II)...